Literature DB >> 28851719

Surgical and Catheter-Based Reinterventions Are Common in Long-Term Survivors of the Fontan Operation.

Tacy E Downing1, Kiona Y Allen2, David J Goldberg2, Lindsay S Rogers2, Chitra Ravishankar2, Jack Rychik2, Stephanie Fuller2, Lisa M Montenegro2, James M Steven2, Matthew J Gillespie2, Jonathan J Rome2, Thomas L Spray2, Susan C Nicolson2, J William Gaynor2, Andrew C Glatz1.   

Abstract

BACKGROUND: There are limited follow-up studies examining surgical and catheter-based reinterventions in long-term survivors of the Fontan operation. METHODS AND
RESULTS: All 773 patients who underwent Fontan at our institution between 1992 and 2009 were retrospectively reviewed. Current information regarding post-Fontan intervention was available for 70%. By 20 years after Fontan, 65% of patients had experienced either surgical or transcatheter intervention. The median time to first reintervention was 9.8 years. Freedom from reoperation was 69% at 15 years and 63% at 20 years. The most common operations were pacemaker placement and Fontan revision. Risk factors for pacemaker placement included systemic left ventricle (hazard ratio [HR], 2.2; P=0.006) and lateral tunnel Fontan (HR, 4.3; P=0.001). Freedom from interventional catheterization was 53% at 15 years and 50% at 20 years. The most common procedures performed were fenestration closure and pulmonary artery intervention. Catheter intervention for anatomic indications was associated with Fontan after 2002 (HR, 2.1; P=0.007), Norwood operation (HR, 2.3; P=0.001), and longer cardiopulmonary bypass time (HR, 1.1 per 10 minutes; P=0.001). Catheter intervention for physiological indications was associated with prolonged post-Fontan pleural drainage (HR, 4.0; P<0.001) and hypoplastic left heart syndrome (HR, 2.0; P=0.01).
CONCLUSIONS: In this study of Fontan survivors, two thirds of patients required surgical or catheter-based reintervention by 20 years. Families should be counseled that the Fontan is typically not the final stage of single-ventricle palliation.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  Fontan procedure; catheterization; cyanosis; hypoplastic left heart syndrome; mortality; tricuspid atresia

Mesh:

Year:  2017        PMID: 28851719     DOI: 10.1161/CIRCINTERVENTIONS.116.004924

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  16 in total

1.  Routine Surveillance Catheterization is Useful in Guiding Management of Stable Fontan Patients.

Authors:  Neil D Patel; Patrick M Sullivan; Arash Sabati; Allison Hill; Chelsea Maedler-Kron; Shengmei Zhou; Nick Shillingford; Roberta Williams; Cheryl Takao; Sarah Badran
Journal:  Pediatr Cardiol       Date:  2020-01-24       Impact factor: 1.655

2.  Troubled Judging of Bronchus Compression Due to Contrast-Filled Balloon in Three-Dimensional Rotational Angiography.

Authors:  Anouk S Moerdijk; Johannes M P J Breur; Mirella M C Molenschot; Gregor J Krings
Journal:  Pediatr Cardiol       Date:  2022-01-16       Impact factor: 1.655

3.  In vivo implantation of 3-dimensional printed customized branched tissue engineered vascular graft in a porcine model.

Authors:  Enoch Yeung; Takahiro Inoue; Hiroshi Matsushita; Justin Opfermann; Paige Mass; Seda Aslan; Jed Johnson; Kevin Nelson; Byeol Kim; Laura Olivieri; Axel Krieger; Narutoshi Hibino
Journal:  J Thorac Cardiovasc Surg       Date:  2019-10-09       Impact factor: 5.209

4.  Prevalent pharmacotherapy of US Fontan survivors: A study utilizing data from the MarketScan Commercial and Medicaid claims databases.

Authors:  Michael L O'Byrne; Jennifer A Faerber; Hannah Katcoff; Jing Huang; Jonathan B Edelson; David M Finkelstein; Bethan A Lemley; Christopher M Janson; Catherine M Avitabile; Andrew C Glatz; David J Goldberg
Journal:  Am Heart J       Date:  2021-09-25       Impact factor: 4.749

Review 5.  Impairments in Pulmonary Function in Fontan Patients: Their Causes and Consequences.

Authors:  Karina Laohachai; Julian Ayer
Journal:  Front Pediatr       Date:  2022-04-15       Impact factor: 3.418

6.  Toward a patient-specific tissue engineered vascular graft.

Authors:  Cameron Best; Robert Strouse; Kan Hor; Victoria Pepper; Amy Tipton; John Kelly; Toshiharu Shinoka; Christopher Breuer
Journal:  J Tissue Eng       Date:  2018-03-16       Impact factor: 7.813

7.  Use of pulmonary vasodilators in Fontan patients: a useful strategy to improve functional status and delay transplantation?

Authors:  Astrid E Lammers; Tilman Humpl
Journal:  Pulm Circ       Date:  2018-08-20       Impact factor: 3.017

Review 8.  Non-invasive Imaging in the Evaluation of Cardiac Shunts for Interventional Closure.

Authors:  Kuberan Pushparajah
Journal:  Front Cardiovasc Med       Date:  2021-06-18

9.  The Fontan procedure is no longer the last operation.

Authors:  Alyssia Venna; Yves d'Udekem
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-15

Review 10.  State of the art of the Fontan strategy for treatment of univentricular heart disease.

Authors:  Jelle P G van der Ven; Eva van den Bosch; Ad J C C Bogers; Willem A Helbing
Journal:  F1000Res       Date:  2018-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.